This activity is intended for BCACPs in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). This series will feature succinct commentaries about practice-changing evidence through a series of podcasts, articles. online panel discussions, and polls. This module consists of 4 activities and offers up to 2 hours of continuing pharmacy education and/or recertification credit. These activities are produced in conjunction with iForumRx and are part of the APhA professional development program for BCACP recertification approved by BPS.
Additional Modules can be found here:
At the completion of this activity, the participant will be able to:
Addressing the Concerns and Needs of Transgender Persons
LO1: Identify specific health and social issues affecting the TGNC population
LO2: Utilize appropriate resources for increasing knowledge on TGNC care
LO3: Identify the recommended survey methods for minority and marginalized patient populations
LO4: Apply techniques to demonstrate cultural sensitivity to TGNC individuals
The Importance of a Healthy Mind in Patients with an Unhealthy Heart: The Effect of Escitalopram vs Placebo for Treatment of Depression in Patients with Acute Coronary Syndrome
LO1: Choose the potential mechanism(s) contributing to the relationship between depression and acute coronary syndrome (ACS).
LO2: Identify which antidepressant medications may worsen cardiovascular outcomes from those that may benefit cardiovascular outcomes in patients who are post-ACS.
LO3: Given a patient scenario, recommend antidepressant therapy that is considered safe from a cardiovascular perspective in patients who are post-ACS that may benefit from treatment of depression.
Medication Synchronization: Friend or Foe?
LO1: Describe the medication synchronization (med sync or similar) program process for managing patient prescriptions for new and refilled medications.
LO2: Evaluate the med sync (or similar) programs in the ambulatory care arena as they apply to opportunities for patient intervention.
LO3: Discuss the role of med sync programs in pharmacy STAR ratings and Medicare performance markers.
Using CRP in COPD to Guide Treatment Decisions during Exacerbations
LO1: Recommend a treatment plan for a patient with a COPD exacerbation.
LO2: Identify when point-of-care C-reactive protein testing may be used to decide whether to prescribe antibiotics for COPD exacerbations based on the PACE study.
LO3: Utilize point-of-care C-reactive protein testing results to decide whether to prescribe antibiotics for COPD exacerbations based on the PACE study.
LO4: Recognize regulations regarding point-of-care testing.
Activity type: Application-based
Target Audience: Pharmacists
Learning level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 2 contact hours of CPE credit (0.2 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-293-H04-P.
To obtain 2 contact hours of CPE credit (0.2 CEUs) for Evidence-Based Practice Module 4, complete the learning activities, assessment with a grade of 71% or better, and evaluation questions.
Per Board of Pharmacy Specialties (BPS) requirements, you will have one opportunity to successfully complete this continuing pharmacy education assessment. Please note that you will not be permitted to submit the assessment a second time. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.
You do not need to complete assessment in one sitting. Once successfully completed, you will be able to claim credit. Participants will need to have a valid APhA (pharmacist.com) username and password, as well as a CPE Monitor account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: December 5, 2019
Expiration date: December 5, 2022
Evidence-Based Practice Module 4 is an online educational activity for pharmacists developed by the American Pharmacists Association.
APhA’s editorial staff declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-19-293-H04-P||0.2 CEUs||December 05, 2019 - December 05, 2022|
|0202-0000-19-293-H04-P||2 Hours||December 05, 2019 - December 05, 2022|